DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /IndazolesIndazoles
  6. /PROTAC HK2 Degrader-1PROTAC HK2 Degrader-1
Chemical structure of CAS 3033812-84-6

PROTAC HK2 Degrader-1

CAS No.3033812-84-6
MDL No.N/A
MFC32H28Cl2N6O5
MW647.50
InChI KeyOFEUWOIETWIJID-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.3033812-84-6
Product NamePROTAC HK2 Degrader-1
Heavy Atom Count45Rotatable Bond Count10
Atom Stereo Count1Bond Stereo Count0
HBA8HBD3
TPSA142.500 ŲCharge0
Exact Mass646.14982Complexity1872.06
pKa5.875XLogP4.415

Documentation

Similar Products

  • Pomalidomide 4'-alkylC7-amine

    CAS No.2446474-05-9

  • 4-((6-Bromohexyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione

    CAS No.2355289-53-9

  • Pomalidomide 4'-alkylC3-acid

    CAS No.2225940-47-4

  • Pomalidomide-C2-NH2 hydrochloride

    CAS No.2305369-00-8

  • Pomalidomide-C2-amide-C4-Br

    CAS No.2545963-02-6

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact